Hyperphenylalaninemia reduces creatine kinase activity in the cerebral cortex of rats

International Journal of Developmental Neuroscience

Volumn 21, Issue 2, 2003, Pages 111-116

  Costabeber, Elisa ^a   Kessler, Adriana ^a   Dutra Filho, Carlos Severo ^a   De Souza Wyse, Angela Terezinha ^a   Wajner, Moacir ^a   Wannmacher, Clóvis Milton Duval ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Creatine kinase; Hyperphenylalaninemia; Phenylalanine; Phenylketonuria

Indexed keywords

CREATINE KINASE; ENZYME INHIBITOR; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; PHENYLALANINE 4 MONOOXYGENASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HOMEOSTASIS; HYPERPHENYLALANINEMIA; IN VITRO STUDY; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; RAT;

ANIMALS; CEREBRAL CORTEX; CREATINE KINASE; ENZYME INHIBITORS; PHENYLALANINE; PHENYLKETONURIAS; RATS; RATS, WISTAR;

RATTUS NORVEGICUS;

EID: 0037375298     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(02)00108-9     Document Type: Article

References (31)

1. Aksenov M.Y., Aksenova M.V., Payne R.M., Smith C.D., Markesbery W.R., Carney J.M. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease. Exp. Neurol. 146:1997;458-465.
2. Aksenov M.Y., Aksenova M.V., Butterfield A.D., Markesbery W.R. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J. Neurochem. 74:2000;2520-2527.
3. Aksenova M.V., Aksenov M.Y., Payne R.M., Trojanovski J.Q., Schmidt K.L., Carney J.M., Butterfield D.A., Markesbery W.R. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobes of neurodegenerative disorders. Dement. Geriatr. Cogn. Disord. 10:1999;158-165.
4. Bauman M.L., Kemper T.L. Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol. 58:1982;55-60.
5. Beal M.F. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23:2000;298-304.
6. Brustovetsky N., Brustovetsky T., Dubinsky J.M. On the mechanisms of neuroprotection by creatine and phosphocreatine. J. Neurochem. 76:2001;425-434.
7. Chevillard C., Cárdenas M.L., Cornish-Bowden A. The competition plot: a sample test of whether two relations occur at the same active site. J. Biochem. 289:1993;599-604.
8. David S.S., Shoemaker M., Haley B.E. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabelling with aberrant cytosol-membrane partitioning. Mol. Brain Res. 54:1998;276-287.
9. 32P into cytoskeletal cerebral proteins Neurochem. Int. 26:1995;381-385.
10. Dougan D.F., Duffield A.M., Duffield P.H., Wade D.N. The effects of (+)-amphetamine, alpha-methyltyrosine, and alpha-methylphenylalanine on the concentrations of m-tyramine and alpha-methyl-m-tyramine in rat striatum. Br. J. Pharmacol. 80:1983;309-314.
11. Hasselbach S., Knudsen G.M., Toft P.B., Hogh P., Tedeschi E., Holm S., Videbaek C., Henriksen O., Lou H.C., Paulson O.B. Cerebral glucose metabolism is decreased in white matter changes in patients with phenylketonuria. Pediatr. Res. 40:1996;21-24.
12. Hemmer W., Wallimann T. Functional aspects of creatine kinase in brain. Dev. Neurosci. 15:1993;249-260.
13. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenova M.V., Aksenov M.Y., Gabbita S.P., Carney J.M., Lowell M., Markesbery W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
14. Himwich, H.E., 1951. Brain Metabolism and Cerebral Disorders. Williams & Wilkins, Baltimore.
15. Hughes B.P. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin. Chim. Acta. 7:1962;597-603.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Manos P., Bryan G.K., Edmond J. Creatine kinase activity in postnatal rat brain development and in cultured neurons, astrocytes, and oligodendrocytes. J. Neurochem. 56:1991;2101-2107.
18. Möller H., Weglage J., Wiedermann D., Vermathen P., Bick U., Ullrich K. Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo. Brain Res. 778:1997;329-337.
19. Rodrigues N.R., Wannmacher C.M.D., Dutra-Filho C.S., Pires R.F., Fagan P.R., Wajner M. Effect of phenylalanine, p-chlorophenylalanine and α-methylphenylalanine on glucose uptake in vitro by the brain of young rats. Biochem. Soc. Trans. 18:1990;419.
20. Saks V.A., Ventura-Clapier R., Aliev M.K. Metabolic control and metabolic capacity: two aspects of creatine kinase functioning in the cells. Biochim. Biophys. Acta. 1274:1996;81-88.
21. Schinder A.F., Olson E.C., Spitzer N.C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16:1996;6125-6133.
22. Scriver, C.R., Kaufman, S., 2001. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.), The Metabolic and Molecular Bases of Inherited Diseases, eighth ed. McGraw-Hill, New York, pp. 1667-1724.
23. Tarnopolsky M.A., Beal M.F. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann. Neurol. 49:2001;571-594.
24. Tomimoto H., Yamamoto K., Homburger H.A., Yanagihara T. Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils. Acta Neuropathol. 86:1993;447-455.
25. Wallimann T., Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 133/134:1994;193-220.
26. Wallimann T., Wyss M., Brdiczka D., Nicolay K. Intracellular compartmentation, struture and function of creatine kinase in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 281:1992;21-40.
27. Wallimann T., Dolder M., Schlattner U., Eder M., Hornemann T., O'Gorman E., Ruck E., Brdiczka D. Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. BioFactors. 8:1998a;229-234.
28. Wallimann T., Dolder M., Schlattner U., Eder M., Hornemann T., Kraft T., Stolz M. Creatine kinase: an enzyme with a central role in cellular energy metabolism. MAGMA. 6:1998b;116-119.
29. Wyse A.T.S., Sarkis J.J.F.S., Cunha-Filho J.S., Teixeira M.V., Schetinger M.R., Wajner M., Wannmacher C.M.D. Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex. Neurochem. Res. 19:1994;1175-1180.
30. +-ATPase activity in the synaptic plasma membrane from the cerebral cortex of rats subjected to chemically induced phenylketonuria. Med. Sci. Res. 23:1995;261-262.
31. +-ATPase activity by phenylalanine and phenyllactate in the synaptic plasma membrane from the cerebral cortex of rats. Med. Sci. Res. 26:1998;141-143.